SHOP BY GOAL · SOUTH AFRICA
Triple-agonist and GH-secretagogue compounds studied for visceral fat oxidation, GLUT4 glucose uptake and lean muscle preservation.
Body recomposition research pairs incretin multi-agonists with GH-secretagogues to investigate simultaneous visceral adipose lipolysis, GLUT4 glucose uptake, and lean muscle sparing.
While the compounds above restock, these ship today.
Incretin receptor agonists and growth hormone releasing peptides.
Visceral fat-to-muscle ratio, hepatic lipid clearance, HOMA-IR insulin sensitivity, and basal metabolic rate.
Long-term receptor desensitization kinetics under high-volume recomposition protocols.
Two different switches for the same pulse
Growth hormone release is controlled from two receptors: the GHRH receptor and the ghrelin receptor. Tesamorelin is a GHRH analogue; Ipamorelin is a selective ghrelin-receptor agonist. Human studies of the two receptor classes given together report a larger GH response than either alone, which is the reasoning behind the Recomposition stack.
The mitochondrial fuel line
NAD+ is the coenzyme that mitochondria use to turn food into cellular energy and that sirtuin enzymes depend on; its levels fall with age. MOTS-c is a peptide encoded in mitochondrial DNA, studied for activating AMPK, the cell’s energy sensor. One is the fuel carrier, the other a signal about how to use it.
Reported research findings, mostly from cell and animal models. Not health claims; for research use only.
LIVING WATER LABS · RESEARCH GRADE
The compounds on this page, CoA-tested and in stock. Dispatch in 1-2 days.
FREQUENTLY ASKED
Two primary research classes: Incretin multi-agonists (such as Retatrutide, a GLP-1/GIP/glucagon triple agonist, and Tirzepatide, a dual GIP/GLP-1 agonist) studied for appetite regulation and metabolic rate, alongside GH-secretagogues (Tesamorelin, Ipamorelin) for preserving lean muscle mass during caloric deficits. Supplied strictly for research use.
Preclinical and clinical trial data show glucagon receptor activation increases basal hepatic energy turnover and accelerates brown adipose tissue thermogenesis, driving preferential visceral fat oxidation while maintaining lean tissue.
Dual GIP/GLP-1 and triple agonists enhance pancreatic beta-cell insulin secretion dynamics and promote peripheral GLUT4 translocation in skeletal muscle, dramatically lowering homeostatic model insulin resistance (HOMA-IR) in research models.
SEE THE RESEARCH & EVIDENCE
GO DEEPER
EXPLORE BY GOAL
All products supplied for research purposes only. Not for human consumption.
Start from what you want to change rather than from a compound name. Every goal below opens a full vertical — what the research points to, what we stock for it, and how to run it.
Systemic wellness — the compounds most studied for how you age, recover overnight and feel day to day.
Training, recovery and tissue-repair research — for getting back to the gym, the field or the trail sooner.
Start from what you want to change — skin, hair, focus, mood, libido — and see what research points to.
Curated entry points for specific researchers — women, veterinary work, first-timers and bulk buyers.
